Left ventricular growth response to exercise and cigarette smoking: Data from LARGE Heart

Heart

Volumn 92, Issue 12, 2006, Pages 1784-1788

  Payne, J R ^a   Eleftheriou, K I ^a   James, L E ^a   Hawe, E ^a   Mann, J ^a   Stronge, A ^b   Kotwinski, P ^a   World, M ^c   Humphries, S E ^a   Pennell, D J ^d   Montgomery, H E ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b Army Training Regiment Lichfield   (United Kingdom)

^c QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARMY; ARTICLE; BODY HEIGHT; BODY WEIGHT; CIGARETTE SMOKING; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; EXERCISE; GROWTH; HEART LEFT VENTRICLE MASS; HUMAN; HUMAN EXPERIMENT; MALE; MULTIVARIATE ANALYSIS; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; STIMULUS RESPONSE; SYSTOLIC BLOOD PRESSURE; UNIVARIATE ANALYSIS;

EID: 33845224326     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2006.088294     Document Type: Article

References (39)

1. Devereux RB. Left ventricular geometry, pathophysiology and prognosis. J Am Coll Cardiol 1995;25:885-7.
2. Post WS, Larson MG, Levy D. Impact of left ventricular structure on the incidence of hypertension. The Framingham Heart Study. Circulation 1994;90:179-85.
3. de Simone G, Daniels SR, Devereux RB, et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 1992;20:1251-60.
4. Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence and mortality in the Framingham Study. Ann Intern Med 1969;71:89-101.
5. Massie BM, Tubau JF, Szlachcic J, et al. Hypertensive heart disease: the critical role of left ventricular hypertrophy. J Cardiovasc Pharm 1989;13(Suppl 1):S18-24.
6. Vogt M, Motz WH, Schwartzkopf B, et al. Pathophysiology and clinical aspects of hypertensive hypertrophy. Eur Heart J 1993;14(Suppl D):2-7.
7. Schaible TF, Scheur J. Cardiovascular adaptations to chronic exercise. Prog Cardiovasc Dis 1985;27:297-324.
8. Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-6.
9. Lombardo RMR, Traina M, Rotolo A, et al. Cardiac hypertrophy in athletes. N Eng J Med 1991;324:1813-14.
10. Cicconetti P, Morelli S, Ottaviani L, et al. Blunted nocturnal fall in blood pressure and left ventricular mass in elderly individuals with recently diagnosed isolated systolic hypertension. Am J Hypertens 2003;16(Pt 1):900-5.
11. Stiefel P, Miranda ML, Rodriguez-Puras MJ, et al. Glucose effectiveness is strongly related to left ventricular mass in subjects with stage I hypertension or high-normal blood pressure. Am J Hypertens 2004;17:146-53.
12. Papavassiliou DP, Treiber FA, Strong WB, et al. Anthropometric, demographic, and cardiovascular predictors of left ventricular mass in young children. Am J Cardiol 1996;78:323-6.
13. Myerson SG, Montgomery HE, Whittingham M, et al. Left ventricular hypertrophy with exercise and ACE gene insertion/deletion polymorphism: a randomized controlled trial with losartan. Circulation 2001;103:226-30.
14. Montgomery HE, Clarkson P, Dollery CM, et al. Association of angiotensin-converting enzyme gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 1997;96:741-7.
15. Richey PA, Brown SP. Pathological versus physiological left ventricular hypertrophy: a review. J Sports Sci 1998;16:129-41.
16. Bellenger NG, Davies LC, Francis JM, et al. Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2000;2:271-8.
17. Moon JC, Lorenz CH, Francis JM, et al. Breath-hold FLASH and FISP cardiovascular MR imaging: left ventricular volume differences and reproducibility. Radiology 2002;223:789-97.
18. Grothues F, Smith GC, Moon JC, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002;90:29-34.
19. Verdecchia P, Schillaci G, Borgioni C, et al. Cigarette smoking, ambulatory blood pressure and cardiac hypertrophy in essential hypertension. J Hypertens 1995;13:1209-15.
20. Liebson PR, Grandits G, Prineas R, et al. Echocardiographic correlates of left ventricular structure among 844 mildly hypertensive men and women in the Treatment of Mild Hypertension Study (TOMHS). Circulation 1993;87:476-86.
21. Maheshwari VD, Pillai A. Influence of smoking and hypertension on left ventricular mass. J Assoc Physicians India 2000;48:397-9.
22. Mahmud A, Feely J. Effect of smoking on arterial stiffness and pulse pressure amplification. Hypertension 2003;41:183-7.
23. Smith CJ, Fischer TH. Particulate and vapor phase constituents of cigarette mainstream smoke and risk of myocardial infarction. Atherosclerosis 2001;158:257-67.
24. Kjeldsen K, Thomsen HK, Astrup P. Effects of carbon monoxide on myocardium. Ultrastructural changes in rabbits after moderate, chronic exposure. Circ Res 1974;34:339-48.
25. Penn A, Snyder C. Arteriosclerotic plaque development is 'promoted' by polynuclear aromatic hydrocarbons. Carcinogenesis 1988;9:2185-9.
26. Benowitz NL. The role of nicotine in smoking-related cardiovascular disease. Prev Med 1997;26:412-17.
27. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 2004;43:1731-7.
28. Kugiyama K, Yasue H, Ohgushi M, et al. Deficiency in nitric oxide bioactivity in epicardial coronary arteries of cigarette smokers. J Am Coll Cardiol 1996;28:1161-7.
29. McVeigh GE, Lemay L, Morgan D, et al. Effects of long-term cigarette smoking on endothelium-dependent responses in humans. Am J Cardiol 1996;78:668-72.
30. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 1989;298:784-8.
31. Reaven G, Tsao PS. Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardiovascular disease? J Am Coll Cardiol 2003;41:1044-7.
32. Lind L, Andersson PE, Andren B, et al. Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome. J Hypertens 1995;13:433-8.
33. Verdecchia P, Reboldi G, Schillaci G, et al. Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension. Circulation 1999;100:1802-7.
34. Lee WO, Wright SM. Production of endothelin by cultured human endothelial cells following exposure to nicotine or caffeine. Metabolism 1999;48:845-8.
35. Cucina A, Sapienza P, Corvino V, et al. Nicotine-induced smooth muscle cell proliferation is mediated through bFGF and TGF-beta 1. Surgery 2000;127:316-22.
36. Penney DG, Barthel BG, Skoney JA. Cardiac compliance and dimensions in carbon monoxide-induced cardiomegaly. Cardiovasc Res 1984;18:270-6.
37. Mirza A, Eder V, Rochefort GY, et al. CO inhalation at dose corresponding to tobacco smoke worsens cardiac remodeling after experimental myocardial infarction in rats. Toxicol Sci 2005;85:976-82.
38. Myerson SG, Montgomery HE, World MJ, et al. Left ventricular mass: reliability of M-mode and 2-dimensional echocardiographic formulas. Hypertension 2002;40:673-8.
39. Health Do. Statistics on smoking England, 1976 to 1996. 1998, http://www.dh.gov.uk (accessed 9 Sep 2006).